Lv1
20 积分 2023-03-26 加入
Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline†
20小时前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1天前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
1天前
已完结
No QTc prolongation with CDK 4/6 inhibitor FCN-437c: results of a concentration-QTc analysis from a dedicated study in adult healthy subjects
28天前
已完结
Recent advances of antibody-drug conjugates in treating breast cancer with different HER2 status
2个月前
已完结
Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer
2个月前
已完结
HER2-Low Breast Cancer—Current Knowledge and Future Directions
2个月前
已完结
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
3个月前
已完结
Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems
4个月前
已完结
皖公网安备34019202002308
